DA Davidson Reaffirms Neutral Rating for Prestige Consumer Healthcare (NYSE:PBH)

DA Davidson reissued their neutral rating on shares of Prestige Consumer Healthcare (NYSE:PBHFree Report) in a research report released on Thursday, Benzinga reports. They currently have a $65.00 price target on the stock. DA Davidson also issued estimates for Prestige Consumer Healthcare’s Q1 2025 earnings at $0.86 EPS, FY2025 earnings at $4.41 EPS and FY2026 earnings at $4.80 EPS.

A number of other brokerages have also recently issued reports on PBH. TheStreet raised shares of Prestige Consumer Healthcare from a c+ rating to a b- rating in a report on Monday, February 12th. StockNews.com upgraded Prestige Consumer Healthcare from a buy rating to a strong-buy rating in a research report on Monday, May 13th. Two research analysts have rated the stock with a hold rating, one has given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company has an average rating of Moderate Buy and an average price target of $95.00.

View Our Latest Report on Prestige Consumer Healthcare

Prestige Consumer Healthcare Trading Down 0.5 %

Shares of PBH stock opened at $64.65 on Thursday. The business’s fifty day moving average price is $70.69 and its 200 day moving average price is $65.23. Prestige Consumer Healthcare has a 1-year low of $55.96 and a 1-year high of $75.31. The firm has a market capitalization of $3.23 billion, a PE ratio of 15.50, a P/E/G ratio of 1.83 and a beta of 0.53. The company has a debt-to-equity ratio of 0.68, a current ratio of 3.20 and a quick ratio of 1.92.

Prestige Consumer Healthcare (NYSE:PBHGet Free Report) last issued its earnings results on Tuesday, May 14th. The company reported $1.02 EPS for the quarter, missing the consensus estimate of $1.14 by ($0.12). The company had revenue of $277.00 million for the quarter, compared to analysts’ expectations of $287.42 million. Prestige Consumer Healthcare had a return on equity of 13.48% and a net margin of 18.60%. Prestige Consumer Healthcare’s revenue for the quarter was down 3.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.07 earnings per share. As a group, sell-side analysts forecast that Prestige Consumer Healthcare will post 4.41 EPS for the current fiscal year.

Institutional Investors Weigh In On Prestige Consumer Healthcare

A number of large investors have recently bought and sold shares of PBH. Tidal Investments LLC boosted its stake in shares of Prestige Consumer Healthcare by 4.7% during the first quarter. Tidal Investments LLC now owns 5,748 shares of the company’s stock valued at $417,000 after acquiring an additional 256 shares during the last quarter. Bayesian Capital Management LP purchased a new stake in shares of Prestige Consumer Healthcare during the first quarter worth about $213,000. Public Employees Retirement System of Ohio raised its position in shares of Prestige Consumer Healthcare by 20.5% in the first quarter. Public Employees Retirement System of Ohio now owns 80,950 shares of the company’s stock valued at $5,874,000 after buying an additional 13,760 shares during the last quarter. BOKF NA purchased a new position in shares of Prestige Consumer Healthcare during the first quarter valued at approximately $246,000. Finally, Quadrature Capital Ltd boosted its position in Prestige Consumer Healthcare by 75.8% during the first quarter. Quadrature Capital Ltd now owns 9,193 shares of the company’s stock worth $668,000 after acquiring an additional 3,965 shares during the last quarter. Institutional investors and hedge funds own 99.95% of the company’s stock.

About Prestige Consumer Healthcare

(Get Free Report)

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

Read More

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.